Envista Holdings
NVST · NYSE
About NVST
- Employees
- 12,000
- Headquarters
- Brea, California
- Listed
- Sep 18, 2019
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- envistaco.com
NVST key statistics
- Market cap
- 3.63B
- Price-earnings ratio
- 38.98
- Dividend yield
- —
- Average volume
- 2.60M
- Volume
- 4.86M
- Open price
- $22.74
- High today
- $23.02
- Low today
- $22.62
- 52 Week high
- $30.42
- 52 Week low
- $18.77
Envista Holdings (NVST) at a glance
Envista Holdings (NVST) last traded at $22.97, with a market cap of 3.63B and a price-to-earnings ratio of 38.98.
Today the stock has traded between $22.62 and $23.02. The current price is 1.5% above the day's low and 0.2% below its high.
Volume so far is 4.86M shares, above the average of 2.60M shares a day.
Over the past year Envista Holdings has ranged from $18.77 to $30.42, and now sits 36% of the way up that range.
Envista Holdings met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $0.41 per share against an estimate of $0.3419.
The average analyst price target is $30.43, 32.5% above the current price, from 13 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy38.5%
- Hold61.5%
- Sell0.0%
- Low
- $23.23
- Now
- $22.97
- High
- $36.75
NVST earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 15.5% on average.
- Q3 FY24: reported $0.12 per share against an estimate of $0.0924
- Q4 FY24: reported $0.24 per share against an estimate of $0.2236
- Q1 FY25: reported $0.24 per share against an estimate of $0.2094
- Q2 FY25: reported $0.26 per share against an estimate of $0.2389
- Q3 FY25: reported $0.32 per share against an estimate of $0.279
- Q4 FY25: reported $0.38 per share against an estimate of $0.3292
- Q1 FY26: reported $0.36 per share against an estimate of $0.3188
- Q2 FY26: reported $0.41 per share against an estimate of $0.3419
NVST news
- Press releasePRNewswire
- Press releasePRNewswire
Envista Announces Participation in Baird 2026 Global Healthcare Conference
- Press releaseGlobe Newswire
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
- Press releasePRNewswire
Envista Reports Second Quarter 2026 Results
- Press releasePRNewswire
Envista to Host Investor Day on September 17, 2026
- Press releasePRNewswire
Envista Schedules Second Quarter 2026 Earnings Call
- Press releaseBusiness Wire
Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board
- Press releasePRNewswire
Envista Schedules First Quarter 2026 Earnings Call
Similar companies
Companies in the same industry as Envista Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.